KACTUS have developed a series of immune checkpoint proteins with various tags.
KACTUS: Immune Checkpoint Proteins


KACTUS have developed a series of immune checkpoint proteins with various tags.

KACTUS has developed a full portfolio of tag-free or small-tag cytokines with verified cellular-level bioactivity for various cell culture applications.

KACTUS provides a variety of highly active CD3 proteins, including monomers, dimers, and other forms, to meet the diverse needs of researchers.

KACTUS’ high-quality CD19 proteins are designed for applications such as antibody screening, CAR-T cell therapy development and affinity measurements.

KACTUS has demonstrated via ELISA & SPR binding assays that their MHC-peptide complexes & loaded peptide-ready MHCs have good binding affinity to TCRs.

KACTUS have a range of Class I and Class II MHC Monomer and Tetramer alleles available.

All the analytical tools you need for your research: in vivo products, tetramers, ELISAs, small molecules & proteins (RUO & GMP)!

Using CHP staining, researchers observed active collagen turnover in grafts, indicating that the ECM was being actively remodelled.

RBD-SpyCatcher-mi3 vaccine construct could be a promising candidate for broad protection against SARS-CoV-2 variants, advocating for further clinical testing.

Non-viral chimeric antigen receptor (CAR)-T cells are gaining attention for their cancer-killing ability with reduced side effects. Traditional CAR-T cell engineering relies on lentivirus, which causes random chromosomal integration, permanent CAR expression, and adverse effects from persistent immunologic stimulation. To